Response: BCL6 and outcome in diffuse large B-cell lymphoma: a work in progress

被引：0
|
作者：
Moskowitz, Craig H. [1 ]
Hamlin, Paul A. [1 ]
Zelenetz, Andrew D. [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
BLOOD | 2007年 / 109卷 / 02期
关键词：
D O I：
10.1182/blood-2006-09-044305
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：845 / 845
页数：1
相关论文
共 50 条
  • [31] MYC Expression in Concert with BCL2 and BCL6 Expression Predicts Outcome in Chinese Patients with Diffuse Large B-Cell Lymphoma, Not Otherwise Specified
    Yan, Li-Xu
    Liu, Yan-Hui
    Luo, Dong-Lan
    Zhang, Fen
    Cheng, Yu
    Luo, Xin-Lan
    Xu, Jie
    Cheng, Jie
    Zhuang, Heng-Guo
    PLOS ONE, 2014, 9 (08):
  • [32] A complex case of BCL6 rearrangements in diffuse large cell lymphoma
    Cunningham, J
    Stranks, G
    O'Connor, M
    Sales, M
    Kernohan, N
    Pratt, N
    JOURNAL OF MEDICAL GENETICS, 2002, 39 : S51 - S51
  • [33] BCL2, BCL6, and MYC Rearrangements in Diffuse Large B-Cell Lymphomas (DLBCL)
    Akyurek, N.
    Uner, A.
    Benekli, M.
    Barista, I.
    MODERN PATHOLOGY, 2010, 23 : 283A - 283A
  • [34] BCL2, BCL6, and MYC Rearrangements in Diffuse Large B-Cell Lymphomas (DLBCL)
    Akyurek, N.
    Uner, A.
    Benekli, M.
    Barista, I.
    LABORATORY INVESTIGATION, 2010, 90 : 283A - 283A
  • [35] BCL-2, BCL-6 AND MYC REARRANGEMENTS AND CLINICAL OUTCOME OF DIFFUSE LARGE B-CELL LYMPHOMA
    Sobas, M. S.
    Tojo, M.
    Tubio, M.
    Fraga, M.
    Bello, J. L.
    Forteza, J.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 278 - 279
  • [36] A Small-Molecule BCL6 Inhibitor as an Anti-Proliferative Agent for Diffuse Large B-Cell Lymphoma
    Xing, Yajing
    Guo, Weikai
    Wu, Min
    Xie, Jiuqing
    Huang, Dongxia
    Hu, Pan
    Zhou, Miaoran
    Zhang, Lin
    Zhong, Yadong
    Liu, Mingyao
    Chen, Yihua
    Yi, Zhengfang
    MOLECULAR CANCER THERAPEUTICS, 2025, 24 (01) : 81 - 92
  • [37] Distinctive patterns of BCL6 molecular alterations and their functional consequences in different subgroups of diffuse large B-cell lymphoma
    Iqbal, J.
    Greiner, T. C.
    Patel, K.
    Dave, B. J.
    Smith, L.
    Ji, J.
    Wright, G.
    Sanger, W. G.
    Pickering, D. L.
    Jain, S.
    Horsman, D. E.
    Shen, Y.
    Fu, K.
    Weisenburger, D. D.
    Hans, C. P.
    Campo, E.
    Gascoyne, R. D.
    Rosenwald, A.
    Jaffe, E. S.
    Delabie, J.
    Rimsza, L.
    Ott, G.
    Mueller-Hermelink, H. K.
    Connors, J. M.
    Vose, J. M.
    McKeithan, T.
    Staudt, L. M.
    Chan, W. C.
    LEUKEMIA, 2007, 21 (11) : 2332 - 2343
  • [38] JAK2 Is a Direct BCL6 Target Gene: Implications for Therapy in Diffuse Large B-Cell Lymphoma
    Barber, Ruth
    Zobel, Jenny
    Beck, Daniel
    Evans, Sian
    Elliott, Richard
    Lord, Christopher J.
    Ashworth, Alan
    Porter, Andrew G. C.
    Wagner, Simon D.
    BLOOD, 2014, 124 (21)
  • [39] Prognostic impact of concurrent MYC and BCL6 rearrangements and expression in de novo diffuse large B-cell lymphoma
    Ye, Qing
    Xu-Monette, Zijun Y.
    Tzankov, Alexandar
    Deng, Lijuan
    Wang, Xiaoxiao
    Manyam, Ganiraju C.
    Visco, Carlo
    Montes-Moreno, Santiago
    Zhang, Li
    Dybkaer, Karen
    Chiu, April
    Orazi, Attilio
    Zu, Youli
    Bhagat, Govind
    Richards, Kristy L.
    Hsi, Eric D.
    Choi, William W. L.
    van Krieken, J. Han
    Huh, Jooryung
    Ponzoni, Maurilio
    Ferreri, Andres J. M.
    Parsons, Ben M.
    Moller, Michael B.
    Piris, Miguel A.
    Winter, Jane N.
    Medeiros, L. Jeffrey
    Hu, Shimin
    Young, Ken H.
    ONCOTARGET, 2016, 7 (03) : 2401 - 2416
  • [40] Prognostic Significance of BCL6 Translocation in Diffuse Large B-Cell Lymphoma Patients Treated with R-CHOP.
    Shustik, Jesse
    Steidl, Christian
    Selm, Laurie
    Gascoyne, Randy D.
    BLOOD, 2008, 112 (11) : 1294 - 1295
12345